Kimelman & Baird, LLC Merck & Co., Inc. Transaction History

Kimelman & Baird, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 19, 2024	SELL	$123.8 - $132.96 $21.6 Million - $23.2 Million	-174,129 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$70.31 - $77.77 $319,769 - $353,697	4,548 Added 2.68%	174,129 $13.5 Million
Q3 2019 Dec 10, 2019	SELL	$76.08 - $82.93 $7,608 - $8,293	-100 Reduced 0.06%	169,581 $14.3 Million
Q2 2019 Nov 22, 2019	BUY	$69.84 - $81.59 $11.9 Million - $13.8 Million	169,681 New	169,681 $14.2 Million

3,802

1.92B

13.4M

10.6M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $256B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Kimelman & Baird, LLC, based on Form 13F filings with the SEC.

Stay updated on Kimelman & Baird, LLC with notifications on news.